According to the World Report on Vision, 2.2 billion people worldwide are visually impaired or blind, of which 1 billion are preventable. In China, eye diseases such as cataract and glaucoma are on the rise, and the myopia population exceeds 600 million. To this end, Aier Eye Hospital Group announced that it will invest up to 20 billion yuan in the next ten years to promote the development of global eye health.
As a leading ophthalmic medical institution in China, Aier Ophthalmology not only continues to innovate in medical technology, but also shows a great sense of responsibility and mission in public welfare. Throughout its development in public welfare, from the initial germination of public welfare to today's professional and systematic operation, every step reflects its firm original intention and spirit of great love.
At the beginning of its establishment, Aier Ophthalmology has been actively engaged in public welfare undertakings, providing help to patients with eye diseases in poor areas by donating medical equipment and providing technical support. This stage of public welfare has laid a solid foundation for the development of Aier Ophthalmology in the field of public welfare. With the in-depth development of public welfare, Aier Ophthalmology began to cooperate with ** to jointly carry out the work of blindness prevention and treatment. Through the establishment of special projects and the development of eye disease screening, Aier Ophthalmology actively cooperates with the clinic to provide more comprehensive and professional services for patients with eye diseases.
In years of public welfare practice, Aier Ophthalmology's public welfare behavior has gradually formed a scale effect. The scope of its donations continues to expand, and the types of eye diseases involved are also increasing. At the same time, Aier Ophthalmology also actively cooperates with other public welfare organizations to jointly carry out eye health public welfare undertakings, forming a good public welfare ecosystem. In recent years, Aier Ophthalmology's public welfare undertakings have entered a new stage of systematic and professional operation. By establishing a sound donation mechanism and formulating a clear donation strategy, Aier Ophthalmology's public welfare undertakings are more standardized and efficient. At the same time, Aier Ophthalmology has also strengthened cooperation with famous universities and scientific research institutions at home and abroad to jointly promote the cultivation of ophthalmic talents and the development of academic scientific research.
Zhang Yuewen of Aier Ophthalmology said that Aier Ophthalmology invested 20 billion yuan this time, and this grand plan aims to build an eye health public welfare ecosystem covering a wide range of people, deepen eye health public welfare undertakings through multi-party linkage such as enterprises, associations, and social organizations, and strengthen the cultivation of ophthalmic talents and the development of academic scientific research. The investment will be divided into two parts: 10 billion yuan will be used for eye health public welfare undertakings through the Love Eye Public Welfare Association, including joint efforts with major public welfare organizations to carry out basic eye disease relief projects and establish a complete eye disease assistance systemSet up a special project for the prevention and control of myopia in children and adolescents**;Set up a public welfare area for the treatment of poor people with eye diseases;Set up a special project for the training and improvement of the ability of grassroots ophthalmologists and general practitioners to diagnose eye diseasesSupport ophthalmic epidemiological surveys and research on eye health-related topicsEstablish grassroots eye disease diagnosis support points and donate ophthalmic intelligent diagnostic equipment. Another 10 billion yuan will be focused on the cultivation of ophthalmic talents and the development of academic scientific research through the Xiangjiang Public Welfare Association, such as the establishment of ophthalmic scientific research, strengthening international cooperation, and cultivating high-end ophthalmic talents.
Chen Bang, chairman of Aier Ophthalmology Group, emphasized that this investment is the embodiment of Aier Ophthalmology's original intention and mission of "enabling all people to enjoy the right to eye health", aiming to pursue the harmony and unity of social responsibility and self-development. He also said that experts will be hired to work together to promote the development and progress of human eye health, so that more people can enjoy the right to eye health.